What did @fitunc actually say?
The creator made three distinct claims worth examining. First, that peptides can produce dramatic body composition changes in about three months for beginners. Second, that anhedonia, described as going emotionally "flat and mute," is a major peptide side effect. Third, that peptides function like a "pay to win" advantage, where spending money just produces better results. He also drew a comparison between peptide-related anhedonia and ashwagandha's known emotional blunting effects. To his credit, he was unusually honest about uncertainty, admitting he's "too scared" to use peptides because of the "guinea pig factor" and a lack of long-term safety data. That self-aware caveat is more than most peptide content on TikTok bothers with.
Does the science back this up?
The dramatic transformation claims are where things get complicated. No well-controlled human trials confirm that peptides like BPC-157 or CJC-1295 plus ipamorelin produce the kind of physique changes he's describing in three months. Most rigorous evidence comes from rodent models or small, short-duration human studies with modest effect sizes. Raun et al. (1998, European Journal of Endocrinology) showed growth hormone secretagogues like ipamorelin increased GH pulse amplitude, but increased GH secretion does not automatically translate to dramatic fat loss and muscle gain at the timelines social media implies. The before-and-after videos he's watching are almost certainly confounded by simultaneous anabolic steroid use, caloric deficits, good lighting, and selection bias. That's not speculation; it's the standard problem with anecdotal physique evidence.
What did they get wrong (or right)?
The anhedonia claim deserves a closer look because he gets the mechanism partly right but mislabels the cause. Anhedonia is genuinely associated with peptides, but not the ones typically associated with gym use like BPC-157 or growth hormone secretagogues. The anhedonia connection is primarily documented with MK-677 (ibutamoren) and certain nootropic peptides like Semax and Selank, possibly through dopaminergic and serotonergic pathway modulation. He's also correct that ashwagandha has been linked to emotional blunting. Pratte et al. (2014, Journal of the International Society of Sports Nutrition) and subsequent case reports suggest ashwagandha's anxiolytic effects can, in some users, extend to reduced emotional range. That's a fair comparison in principle. Where he gets things wrong is treating all peptides as a single category with shared side effects. BPC-157, TB-500, and GHK-Cu have entirely different pharmacological profiles than MK-677 or Semax. Lumping them together is like saying all antibiotics cause hearing loss because aminoglycosides do.
What should you actually know?
The "pay to win" framing is catchy but misleading in a specific way. Peptides used in clinical and research contexts, like GHK-Cu for skin repair or BPC-157 for soft tissue healing in animal models, are not simple performance amplifiers you buy your way into. They are pharmacologically active compounds with receptor-level effects that are not fully characterized in humans. The FDA has not approved most of these for therapeutic use, and compounded versions available through telehealth vary widely in purity and dosing accuracy. A 2021 report from the U.S. Pharmacopeial Convention flagged significant quality control inconsistencies in compounded peptide preparations. His instinct that "we don't even really know what the real side effects" are is actually the most scientifically defensible thing he said. Long-term human data on peptides like BPC-157 is essentially nonexistent.
The bottom line on peptide hype vs. evidence
What @fitunc is watching on TikTok, dramatic three-month transformations attributed to peptides, almost certainly reflects confounded anecdotes rather than peptide-specific effects. His fear about long-term unknowns is legitimate and underreported in this content category. The anhedonia concern is real but applies more selectively than he implies. Before anyone pursues peptide therapy, a conversation with a licensed clinician who can review bloodwork, goals, and contraindications is not optional. Social media before-and-afters are not clinical evidence, and the absence of visible side effects in a three-month video is not the same as a clean safety record.